Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Third time is the charm: Radius Health completes $48.4mm IPO after multiple tries

Executive Summary

After two previous failed attempts to go public in the last two years, women’s health and osteoporosis drug developer Radius Health Inc. finally completed its IPO, netting $48.4mm through the sale of 6.5mm shares at $8. The company’s first attempt occurred in February 2012, but terms of 6.5mm shares for $8.50-10.50 were withdrawn later that year. It re-filed in February 2014, hoping to sell 5mm shares at $14-16, but that too was withdrawn just last month, to be followed less than three weeks later by the new filing, which closed shortly thereafter.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Drug Delivery
      • Transdermal
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies